[Abnormal bronchomotor effects of adrenergics. Experimental interpretations and therapeutic deductions].
D000818:Animals; D001249:Asthma / Q000188:drug therapy*; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D004285:Dogs; D004357:Drug Synergism; D004417:Dyspnea / Q000139:chemically induced; D004837:Epinephrine / Q000627:therapeutic use; D006168:Guinea Pigs; D006801:Humans; D007545:Isoproterenol / Q000627:therapeutic use; D013565:Sympatholytics / Q000009:adverse effects / Q000627:therapeutic use*; D013566:Sympathomimetics / Q000627:therapeutic use*; D014043:Tolazoline / Q000627:therapeutic use
D001993:Bronchodilator Agents; D013565:Sympatholytics; D013566:Sympathomimetics; D014043:Tolazoline; D007545:Isoproterenol; D004837:Epinephrine
Les effets broncho-moteurs aberrants des adrénergiques. Interprétations expérimentaeles et déductions thérapeutiques.